MedKoo Cat#: 576099 | Name: GW-833972A free base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

GW833972 is a CB2 Agonist. GW 833972A inhibited capsaicin-induced depolarization of the human and guinea-pig and prostaglandin E(2) (PGE(2)) and hypertonic saline-induced depolarization of the guinea-pig isolated vagus nerve in vitro. GW 833972A also inhibited citric acid-induced cough but not plasma extravasation in the guinea-pig and this effect was blocked by a CB(2) receptor antagonist.

Chemical Structure

GW-833972A free base
GW-833972A free base
CAS#667905-37-5 (free base)

Theoretical Analysis

MedKoo Cat#: 576099

Name: GW-833972A free base

CAS#: 667905-37-5 (free base)

Chemical Formula: C18H13ClF3N5O

Exact Mass: 407.0761

Molecular Weight: 407.78

Elemental Analysis: C, 53.02; H, 3.21; Cl, 8.69; F, 13.98; N, 17.17; O, 3.92

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
GW-833972A free base; GW833972; GW-833972; GW 833972; GW833972A; GW-833972A; GW 833972A;
IUPAC/Chemical Name
2-(3-Chlorophenylamino)-4-trifluoromethylpyrimidine-5-carboxylic acid N-((pyridin-4-yl)methyl)amide
InChi Key
HLCPJLIYGNWTAI-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H13ClF3N5O/c19-12-2-1-3-13(8-12)26-17-25-10-14(15(27-17)18(20,21)22)16(28)24-9-11-4-6-23-7-5-11/h1-8,10H,9H2,(H,24,28)(H,25,26,27)
SMILES Code
FC(F)(F)c1nc(Nc2cccc(Cl)c2)ncc1C(=O)NCc3ccncc3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Solvent mg/mL mM
Solubility
Soluble in DMSO 0.0 100.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 407.78 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: López-Ramírez G, Sánchez-Zavaleta R, Ávalos-Fuentes A, José Sierra J, Paz- Bermúdez F, Leyva-Gómez G, Segovia Vila J, Cortés H, Florán B. D2 autoreceptor switches CB2 receptor effects on [3 H]-dopamine release in the striatum. Synapse. 2020 Mar;74(3):e22139. doi: 10.1002/syn.22139. Epub 2019 Oct 19. PMID: 31610050. 2: Belvisi MG, Patel HJ, Freund-Michel V, Hele DJ, Crispino N, Birrell MA. Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways. Br J Pharmacol. 2008 Oct;155(4):547-57. doi: 10.1038/bjp.2008.298. Epub 2008 Aug 11. PMID: 18695648; PMCID: PMC2579660.